Beyond Diet and Exercise Hydration is Vital: GLP-1 medications can sometimes cause digestive side effects that lead to dehydration
GLP-1 receptor agonists may be considered when additional treatment goals include weight reduction, improved glycemic control, chronic kidney disease risk reduction, or lowering atherosclerotic cardiovascular risk, particularly in patients with obesity or established Atherosclerotic Cardiovascular Disease (ASCVD) [7, 16, 47]
It is not approved for therapeutic use and remains for investigational and laboratory applications
Semaglutide combined protocols Researchers often ask about combining semaglutide with other compounds
Who Should Take Balance My Blood Sugar
When you eat less and make healthier choices, you can lose weight over time